AmpliTest SARS-CoV-2
Designed for the qualitative determination of SARS-CoV-2 coronavirus RNA of severe acute respiratory syndrome (COVID-19) in biological material (smears from the mucous membrane of the nasopharynx and oropharynx, sputum, human feces) by PCR with real-time hybridization-fluorescence detection . The reagent kit is designed for 96 determinations.
| Тип образцов | Диагностическая чувствительность | Диагностическая специфичность |
|---|---|---|
| Мазки из носо- и ротоглотки | 94,3-100% | 95,4-100% |
| Мокрота | 94,4-100% | 94,6-100% |
| Фекалии | 94,3-100% | 94,3-100% |
AmpliTest SARS-CoV-2 VOC v.4
Designed for qualitative determination of SARS-CoV-2 coronavirus RNA of genetic variants of special epidemiological significance (VOC) Omicron (with differentiation of the BA.2 line) and Delta by identifying mutations characteristic of these variants in the S gene of coronavirus in RNA samples extracted from human biological material (smears from the mucous membrane of the nasopharynx and oropharynx), in which SARS-CoV-2 RNA was detected by nucleic acid amplification .
Characteristics
AmpliTest SARS-CoV-2 VOC v.3
Designed for the qualitative determination of SARS-CoV-2 coronavirus RNA of genetic variants of special epidemiological significance (VOC) Omicron and Delta by identifying mutations characteristic of these variants in the coronavirus S gene in RNA samples extracted from human biological material (smears from the nasal and oropharynx) in which SARS-CoV-2 RNA was detected by nucleic acid analysis.
Characteristics
AmpliTest SARS-CoV-2 VOC v.2
Designed for qualitative detection of SARS-CoV-2 coronavirus RNA of genetic lines of special epidemiological significance (VOC) Alpha, Delta and Beta / Gamma by identifying mutations characteristic of these lines in the S gene of coronavirus in RNA samples extracted from human biological material (mucosal swabs) nasopharynx and oropharynx) in which SARS-CoV-2 RNA was detected by nucleic acid analysis
Characteristics
